DK263689D0 - Modificeret baculovirus, fremgangsmaade til dets fremstilling samt dets anvendelse som ekspressionsvektor for gener - Google Patents

Modificeret baculovirus, fremgangsmaade til dets fremstilling samt dets anvendelse som ekspressionsvektor for gener

Info

Publication number
DK263689D0
DK263689D0 DK263689A DK263689A DK263689D0 DK 263689 D0 DK263689 D0 DK 263689D0 DK 263689 A DK263689 A DK 263689A DK 263689 A DK263689 A DK 263689A DK 263689 D0 DK263689 D0 DK 263689D0
Authority
DK
Denmark
Prior art keywords
baculovirus
expression vector
modified
procedure
manufacturing
Prior art date
Application number
DK263689A
Other languages
English (en)
Other versions
DK263689A (da
Inventor
Gerard Devauchelle
Martine Cerutti
Guy Croizier
Liliane Croizier
Original Assignee
Agronomique Inst Nat Rech
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech, Centre Nat Rech Scient filed Critical Agronomique Inst Nat Rech
Publication of DK263689D0 publication Critical patent/DK263689D0/da
Publication of DK263689A publication Critical patent/DK263689A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
DK263689A 1988-05-31 1989-05-30 Modificeret baculovirus, fremgangsmaade til dets fremstilling samt dets anvendelse som ekspressionsvektor for gener DK263689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8807207A FR2631974B1 (fr) 1988-05-31 1988-05-31 Baculovirus modifie, son procede de preparation et son application en tant que vecteur d'expression de genes

Publications (2)

Publication Number Publication Date
DK263689D0 true DK263689D0 (da) 1989-05-30
DK263689A DK263689A (da) 1989-12-01

Family

ID=9366759

Family Applications (1)

Application Number Title Priority Date Filing Date
DK263689A DK263689A (da) 1988-05-31 1989-05-30 Modificeret baculovirus, fremgangsmaade til dets fremstilling samt dets anvendelse som ekspressionsvektor for gener

Country Status (12)

Country Link
US (1) US5583023A (da)
EP (1) EP0345152B1 (da)
JP (1) JP3183877B2 (da)
AT (1) ATE142257T1 (da)
AU (1) AU626867B2 (da)
CA (1) CA1341272C (da)
DE (1) DE68927073T2 (da)
DK (1) DK263689A (da)
FR (1) FR2631974B1 (da)
NO (1) NO892172L (da)
NZ (1) NZ229369A (da)
PT (1) PT90687B (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014428A1 (en) * 1989-05-17 1990-11-29 University Of Georgia Research Foundation, Inc. Improved baculovirus expression vectors
US5244805A (en) * 1989-05-17 1993-09-14 University Of Georgia Research Foundation, Inc. Baculovirus expression vectors
GB9106185D0 (en) * 1991-03-22 1991-05-08 Wellcome Found Biological control agents
TW502065B (en) * 1993-05-28 2002-09-11 American Cyanamid Co Gene insertion by direct ligation in vitro
FR2724182B1 (fr) * 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
FR2724393A1 (fr) * 1994-09-12 1996-03-15 Inst Nat Sante Rech Med Obtention d'un anticorps monoclonal recombinant humanise a partir d'un anticorps monoclonal murin, sa production en cellules d'insecte, et ses utilisations
FR2732035B1 (fr) * 1995-03-23 1997-05-30 Agronomique Inst Nat Rech Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede
US6265193B1 (en) 1997-03-12 2001-07-24 Pe Corporation (Ny) DNA polymerases having improved labeled nucleotide incorporation properties
US20050042629A1 (en) 2002-09-13 2005-02-24 Applera Corporation Thermus scotoductus nucleic acid polymerases
EP2322229B1 (en) 2001-10-10 2016-12-21 Novo Nordisk A/S Remodeling and glycoconjugation of Factor IX
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7416858B2 (en) 2001-10-10 2008-08-26 Neose Technologies, Inc. Pharmaceutical compositions of glycoconjugates
AU2002346498A1 (en) 2001-11-30 2003-06-17 Applera Corporation Thermus brockianus nucleic acid polymerases
MXPA06008507A (es) 2004-02-02 2008-02-13 Ambrx Inc Cuatro polipeptidos en haz helicoidal humanos modificados y sus usos.
KR101699142B1 (ko) 2004-06-18 2017-01-23 암브룩스, 인코포레이티드 신규 항원-결합 폴리펩티드 및 이의 용도
EP1771573A4 (en) 2004-07-21 2009-02-18 Ambrx Inc BIOSYNTHETIC POLYPEPTIDES OBTAINED FROM NON-NATURALLY CITED AMINO ACIDS
EP2284191A3 (en) 2004-12-22 2011-07-20 Ambrx, Inc. Process for the preparation of hGH
BRPI0519568C8 (pt) 2004-12-22 2022-06-14 Ambrx Inc Aminoacil-trna sintetase (rs), composições que compreendem a dita aminoacil-trna sintetase, célula de levedura, célula fúngica, célula não eucariótica, vetor que codifica uma rs, polinucleotídeo e ainda método para produzir um polipeptídeo em uma célula com um aminoácido selecionado em uma posição especificada
KR20070100299A (ko) 2004-12-22 2007-10-10 암브룩스, 인코포레이티드 재조합 인간 성장 호르몬의 발현 및 정제 방법
NZ555386A (en) 2004-12-22 2011-01-28 Ambrx Inc Formulations of human growth hormone comprising a non-naturally encoded amino acid
NZ555308A (en) 2004-12-22 2010-10-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
MX2007015058A (es) * 2005-06-03 2008-01-28 Ambrx Inc Moleculas de interferon humano mejoradas y sus usos.
NZ565294A (en) 2005-08-18 2010-06-25 Ambrx Inc Compositions of tRNA and uses thereof
EP1954710B1 (en) * 2005-11-08 2011-03-02 Ambrx, Inc. Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
CA2626522A1 (en) * 2005-11-16 2007-05-24 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
CN101448512B (zh) * 2005-12-14 2015-11-25 Ambrx公司 含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及非天然氨基酸和多肽的用途
US7745158B2 (en) * 2005-12-14 2010-06-29 Kimberly-Clark Worldwide, Inc. Detection of secreted aspartyl proteases from Candida species
DK2064333T3 (da) * 2006-09-08 2014-05-05 Ambrx Inc Suppressor-trna-transkription i hvirveldyrceller
CN106190983B (zh) * 2006-09-08 2019-05-28 Ambrx公司 用于脊椎动物细胞的杂合抑制tRNA
CN106008699A (zh) * 2006-09-08 2016-10-12 Ambrx公司 经修饰的人类血浆多肽或Fc骨架和其用途
CN104163864B (zh) 2007-03-30 2017-08-01 Ambrx公司 经修饰fgf‑21多肽和其用途
US8114630B2 (en) * 2007-05-02 2012-02-14 Ambrx, Inc. Modified interferon beta polypeptides and their uses
NZ603812A (en) 2007-11-20 2014-06-27 Ambrx Inc Modified insulin polypeptides and their uses
JP5702150B2 (ja) 2008-02-08 2015-04-15 アンブルックス, インコーポレイテッドAmbrx, Inc. 修飾されているレプチンポリペプチドおよびそれらの使用
EP3225248B1 (en) 2008-07-23 2023-06-07 Ambrx, Inc. Modified bovine g-csf polypeptides and their uses
PT2337846T (pt) 2008-09-26 2018-04-05 Ambrx Inc Vacinas e microrganismos dependentes da replicação de aminoácidos não naturais
KR101647164B1 (ko) 2008-09-26 2016-08-09 암브룩스, 인코포레이티드 변형된 동물 에리트로포이에틴 폴리펩티드 및 이의 용도
CN102753573A (zh) 2009-12-21 2012-10-24 Ambrx公司 经过修饰的牛促生长素多肽和其用途
AU2010341518B2 (en) 2009-12-21 2014-01-09 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
PL2605789T3 (pl) 2010-08-17 2019-11-29 Ambrx Inc Zmodyfikowane polipeptydy relaksyny i ich zastosowania
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
US20140017263A1 (en) 2012-06-28 2014-01-16 Clemson University Delivery Agents for Targeted Treatment of Elastin Degradation
CA2899659C (en) 2013-01-28 2023-09-05 Kansas State University Research Foundation Rift valley fever virus glycoproteins, gn and gc, and their use
UY36370A (es) 2014-10-24 2016-04-29 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Polipéptidos fgf-21 modificados y sus usos
BR112019016139A2 (pt) 2017-02-08 2020-04-07 Bristol-Myers Squibb Company polipeptídio de relaxina modificada compreendendo um melhorador farmacocinético e usos do mesmo
WO2020081765A1 (en) * 2018-10-18 2020-04-23 Academia Sinica Method and kit for pesticides detection, and plasmid, baculovirus, cell and method of preparing the same for pesticides detection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1202581A (en) * 1980-03-27 1986-04-01 Saran A. Narang Adaptor molecules for dna and their application to synthesis of gene-derived products
US4419446A (en) * 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
EP0074808A3 (en) * 1981-09-16 1984-07-04 University Patents, Inc. Recombinant method and materials
DE3485810T2 (de) * 1983-05-27 1992-12-10 Texas A & M University Syst Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors.
FR2571737B1 (fr) * 1984-10-15 1987-02-20 Agronomique Inst Nat Rech Vecteurs de clonage ou d'expression comportant le genome du virus de l'erythroblastose aviaire et cellules transfectees par ces vecteurs
IE60285B1 (en) * 1985-12-18 1994-06-29 Microgenesys Inc Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
WO1988007082A1 (en) * 1987-03-16 1988-09-22 American Biogenetic Sciences, Inc. Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
EP0364492A1 (en) * 1987-06-30 1990-04-25 The Upjohn Company Virus proteins having reduced o-linked glycosylation
AU2136788A (en) * 1987-07-24 1989-03-01 Cetus Corporation Production of ricin toxins in a baculovirus-insect cell expression system

Also Published As

Publication number Publication date
JP3183877B2 (ja) 2001-07-09
NO892172D0 (no) 1989-05-30
US5583023A (en) 1996-12-10
PT90687A (pt) 1989-11-30
NO892172L (no) 1989-12-01
JPH0235092A (ja) 1990-02-05
DE68927073T2 (de) 1997-03-27
FR2631974A1 (fr) 1989-12-01
DE68927073D1 (de) 1996-10-10
AU626867B2 (en) 1992-08-13
FR2631974B1 (fr) 1992-12-11
EP0345152A1 (fr) 1989-12-06
EP0345152B1 (fr) 1996-09-04
NZ229369A (en) 1991-07-26
AU3529189A (en) 1989-12-07
CA1341272C (fr) 2001-07-10
PT90687B (pt) 1994-10-31
ATE142257T1 (de) 1996-09-15
DK263689A (da) 1989-12-01

Similar Documents

Publication Publication Date Title
DK263689D0 (da) Modificeret baculovirus, fremgangsmaade til dets fremstilling samt dets anvendelse som ekspressionsvektor for gener
LU91304I2 (fr) A tryn-antithrombin alfa
ES532825A0 (es) Un metodo de sintetizar un polipeptido seleccionado
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
NO179253C (no) Rekombinant DNA-sekvens som koder for humant proapolipoprotein A-I, ekspresjonsvektorer, cellekulturer samt fremgangsmåte for fremstilling av proteinet
EP0783321A4 (en) VIRAL NUCLEOTIDE SEQUENCE VR-2332 AND METHOD OF USE
DK645887A (da) Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse
FI944136A0 (fi) Koostumuksia ja menetelmä sialyylitransferaasien identifioimiseksi ja syntesoimiseksi
DE69217144D1 (de) Regulator-DNA zur Gen-Expression
PT83968B (pt) Processo para melhoramento da expressao de proteina eucariotica, de preparacao de um plasmideo e plasmideo
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
DK315582A (da) T4 dna-fragment som stabilisator for proteiner udtrykt ved klonet dna
GB8615263D0 (en) Light inducible promoter
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
ATE116687T1 (de) Stamm ral-4, nützlich zur herstellung kleiner proteine und peptide.
EA200100440A1 (ru) Ген prv-1 и его применение
SE9101740L (sv) Nya dna fragment och sekvenser
JPS6474988A (en) Synthetic gene of cystatin c, corresponding recombinant plasmid and recombinant

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment